Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Clinical utility study data: further highlights

December 1, 2022
RNS Number : 1709I Renalytix PLC 01 December 2022     Renalytix plc ("Renalytix" or the "Company")   Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes   First-in-class bioprognostic™ KidneyIntelX provided clear direction for primary care physicians to

Results for First Quarter of Fiscal Year 2023

November 30, 2022
RNS Number : 0037I Renalytix PLC 30 November 2022   Renalytix plc ("Renalytix" or the "Company")   Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023   LONDON and SALT LAKE CITY , November 30, 2022   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial

Publication of new real world evidence

November 29, 2022
RNS Number : 8468H Renalytix PLC 29 November 2022       Renalytix plc ("Renalytix" or the "Company")   Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease   Risk scoring by KidneyIntelX

Notice of Q1 FY23 Results

November 22, 2022
RNS Number : 1356H Renalytix PLC 22 November 2022       Renalytix plc ("Renalytix" or the "Company")   Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30   LONDON and SALT LAKE CITY , November 22, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that

Publication of Annual Report 2022 & Notice of AGM

November 10, 2022
RNS Number : 9096F Renalytix PLC 10 November 2022     Renalytix plc ("Renalytix" or the "Company")   Publication of Annual Report 2022 and Notice of 2022 Annual General Meeting   LONDON and SALT LAKE CITY, UT   November 10, 2022 -   Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Annual

Price Monitoring Extension

November 9, 2022
RNS Number : 8850F Renalytix PLC 09 November 2022   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

RENX to Present at Stifel Healthcare Conference

November 3, 2022
RNS Number : 1206F Renalytix PLC 03 November 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix   to Present at Stifel Healthcare Conference   NEW YORK, NY and SALT LAKE CITY, UT    ̶  November 3, 2022   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will

Second Price Monitoring Extn

October 31, 2022
RNS Number : 7950E Renalytix PLC 31 October 2022   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

Price Monitoring Extension

October 31, 2022
RNS Number : 7941E Renalytix PLC 31 October 2022   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

Renalytix Reports Full Year Fiscal 2022 Results

October 31, 2022
RNS Number : 5791E Renalytix PLC 31 October 2022   Renalytix plc (" Renalytix ", the "Group" or the " Company ")   Renalytix Reports Full Year Fiscal 2022 Results   LONDON and SALT LAKE CITY , October 31, 2022   -  Renalytix plc   (NASDAQ: RNLX),  (LSE : RENX)   an artificial intelligence-enabled
Displaying 1 - 10 of 224